Legal Representation
Attorney
Sharon R. Smith
USPTO Deadlines
Next Deadline
1979 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-17)
Due Date
December 17, 2030
Grace Period Ends
June 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 1, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Dec 17, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 17, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 20, 2024 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Oct 15, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 15, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 25, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 8, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 8, 2024 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
| Sep 8, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 9, 2024 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
| Aug 9, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 9, 2024 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
| Jun 18, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 15, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting collaboration within the scientific, research and provider communities to achieve advances in the fields of treatment, diagnosis and prophylaxis of cancers and hematologic diseases, syndromes and disorders.
First Use Anywhere:
Feb 20, 2024
First Use in Commerce:
Feb 20, 2024
Class 044
Providing medical information in the field of the diagnosis and treatment of cancers and hematologic malignancies to consumers, and providing medical information in the field of prevention, screening, diagnosis and treatment to scientists, researchers and medical providers on cancers and hematologic diseases, syndromes and disorders.
First Use Anywhere:
Feb 20, 2024
First Use in Commerce:
Feb 20, 2024
Classification
International Classes
035
044